S&P Global Inc (SPGI):企業の財務・戦略的SWOT分析

◆英語タイトル:S&P Global Inc (SPGI) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1488
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Financial Services
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

S&P Global Inc (SPGI) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

S&P Global Inc (SPGI) is a provider of financial intelligence solutions. It offers credit ratings, benchmarks, data, and digital and traditional financial research and analytical tools to the capital and commodity markets globally. The company provides cross-asset analytics, multi-asset-class data, desktop services, benchmark prices, and investment information. SPGI is a provider of a global index that maintains a range of indices and index benchmarks. It offers price data, and industry insight that enables commodities markets; and consumer intelligence services. It operates in the Americas, Europe, and Asia. SPGI is headquartered in New York, the US.

S&P Global Inc Key Recent Developments

Jan 30,2020 Ecolab’s Water Risk Monetizer updates Global Water data to reflect current trends

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
S&P Global Inc – Key Facts
S&P Global Inc – Key Employees
S&P Global Inc – Key Employee Biographies
S&P Global Inc – Major Products and Services
S&P Global Inc – History
S&P Global Inc – Company Statement
S&P Global Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
S&P Global Inc – Business Description
Business Segment: Corporate
Overview
Performance
Business Segment: Indices
Overview
Performance
Business Segment: Market Intelligence
Overview
Performance
Business Segment: Platts
Overview
Performance
Business Segment: Ratings
Overview
Performance
Geographical Segment: Asia
Target Markets
Performance
Geographical Segment: European Region
Target Markets
Performance
Geographical Segment: Rest of the World
Target Markets
Performance
Geographical Segment: U.S.
Target Markets
Performance
S&P Global Inc – Corporate Strategy
S&P Global Inc – SWOT Analysis
SWOT Analysis – Overview
S&P Global Inc – Strengths
S&P Global Inc – Weaknesses
S&P Global Inc – Opportunities
S&P Global Inc – Threats
S&P Global Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Recent Developments
Jan 30, 2020: Ecolab’s Water Risk Monetizer updates Global Water data to reflect current trends
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
S&P Global Inc, Key Facts
S&P Global Inc, Key Employees
S&P Global Inc, Key Employee Biographies
S&P Global Inc, Major Products and Services
S&P Global Inc, History
S&P Global Inc, Other Locations
S&P Global Inc, Subsidiaries
S&P Global Inc, Key Competitors
S&P Global Inc, Ratios based on current share price
S&P Global Inc, Annual Ratios
S&P Global Inc, Annual Ratios (Cont...1)
S&P Global Inc, Annual Ratios (Cont...2)
S&P Global Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
S&P Global Inc, Performance Chart (2015 - 2019)
S&P Global Inc, Ratio Charts

★海外企業調査レポート[S&P Global Inc (SPGI):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ORIX Corporation:企業のM&A・事業提携・投資動向
    ORIX Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ORIX Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Fuji Electric Co., Ltd.:企業の戦略・SWOT・財務分析
    Fuji Electric Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Fuji Electric Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Inoviem Scientific SAS-製薬・医療分野:企業M&A・提携分析
    Summary Inoviem Scientific SAS (Inoviem) is a contract research biotechnology company that offers preclinical and clinical services. The company develops solutions in the field of drug target interaction analysis and drug development. Its technologies include physiological intermolecular modulation …
  • 4D Molecular Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary 4D Molecular Therapeutics Inc (4D Molecular Therapeutics) is a gene therapy company that deliver genes to specific cells in the body to eradicate rare and large market diseases. The company discovers and develops targeted and proprietary AAV gene therapy vectors and therapeutic products. It …
  • UNeMed Corp-製薬・医療分野:企業M&A・提携分析
    Summary UNeMed Corp (UneMed), a subsidiary of University of Nebraska Medical Center is a healthcare service provider that offers technology transfer and commercialization services. The company offers services such as inventions, material transfer, confidentiality, intellectual property, startup form …
  • GeNeuro SA (GNRO):企業の財務・戦略的SWOT分析
    Summary GeNeuro SA (GeNeuro) operates as a clinical stage pharmaceutical company that manufactures therapeutic product pipeline for disorders of the nervous system. The company provides treatments against inflammatory and degenerative disorders associated with endogenous retroviruses. GeNeuro develo …
  • Advanced Catheter Therapies Inc:医療機器:M&Aディール及び事業提携情報
    Summary Advanced Catheter Therapies Inc (ACT) is a medical device company that provides novel catheter technologies targeting vascular disease such as inflammation, thrombosis, occlusions and restenosis. The company is developing a device for restenosis and catheters for endovascular debulking. It o …
  • Tsurumi Manufacturing Co Ltd (6351):企業の財務・戦略的SWOT分析
    Tsurumi Manufacturing Co Ltd (6351) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • The Tata Power Co Ltd (TATAPOWER):企業の財務・戦略的SWOT分析
    The Tata Power Co Ltd (TATAPOWER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Shimano Inc (7309):企業の財務・戦略的SWOT分析
    Shimano Inc (7309) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Amgen Inc (AMGN)-製薬・医療分野:企業M&A・提携分析
    Summary Amgen Inc (Amgen) is a biotechnology company that discovers, develops, manufactures and markets innovative human therapeutics to improve the lives of patients suffering from serious diseases. It develops novel medicines in six focused therapeutic areas including cardiovascular disease, oncol …
  • Animal Health International Inc:企業の戦略的SWOT分析
    Animal Health International Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • CaroGen Corp-製薬・医療分野:企業M&A・提携分析
    Summary CaroGen Corp (CaroGen) is a vaccine company that offers platform technology development services. The company develops and commercializes nanoparticle therapeutic vaccines. It utilizes its virus-like vesicle platform technology, a proprietary replication competent to develop nano particle th …
  • Royal Dutch Shell plc:企業のM&A・事業提携・投資動向
    Royal Dutch Shell plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Royal Dutch Shell plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Infant Bacterial Therapeutics AB (IBT B)-製薬・医療分野:企業M&A・提携分析
    Summary Infant Bacterial Therapeutics AB (IBT), a subsidiary of BioGaia AB is a pharmaceutical company that develops prophylactic therapies for the medical needs of the premature infant. The company develops pharmaceutical drug candidates for gastrointestinal neonatal condition that causes mucosal i …
  • Samchully Co Ltd (004690):企業の財務・戦略的SWOT分析
    Samchully Co Ltd (004690) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Lipocine Inc (LPCN):企業の財務・戦略的SWOT分析
    Summary Lipocine Inc (Lipocine) is a pharmaceutical company that develops and commercializes treatment for men's and women's health. The company’s pipeline products for men’s health include LPCN 1111 and LPCN 1021; and for women’s health include LPCN 1107. Its LPCN 1111 is an oral testosterone produ …
  • Newfoundland Power Inc.:企業の戦略的SWOT分析
    Newfoundland Power Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Australian Leaders Fund Limited:企業の戦略・SWOT・財務情報
    Australian Leaders Fund Limited - Strategy, SWOT and Corporate Finance Report Summary Australian Leaders Fund Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • MicuRx Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary MicuRx Pharmaceuticals Inc (MicuRx) is a developer of antibiotics for drug-resistant bacterial infections. The company develops a pipeline of antimicrobial agents using its proprietary drug discovery platform to treat both gram-positive and gram-negative bacterial infections. It offers produ …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆